Yatsen Holding Limited (NYSE:YSG) entered into an agreement to acquire mainland China business of Dr. Wu Skincare Co., Ltd. (TPEX:6523) in November 2020. Transaction will leverage the brand equity, proven products and formulations, combined with our DTC model and platform capabilities, to bring the brand to next level.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | +2.74% | -0.88% | +23.02% |
11/04 | Yatsen Holding Regains Compliance With NYSE Minimum Share Price Requirement | MT |
15/03 | ADRs End Lower; Akso Health Group Declines 23% | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.02% | 48Cr | |
-0.68% | 26TCr | |
+19.72% | 2.08TCr | |
0.00% | 1.94TCr | |
+15.62% | 1.26TCr | |
-14.17% | 920.23Cr | |
+10.20% | 598.44Cr | |
-2.43% | 446Cr | |
-13.55% | 398.69Cr | |
-5.97% | 365.02Cr |
- Stock Market
- Equities
- YSG Stock
- News Yatsen Holding Limited
- Yatsen Holding Limited entered into an agreement to acquire mainland China business of Dr. Wu Skincare Co., Ltd..